ANTIPLATELET THERAPY
Clinical trials for ANTIPLATELET THERAPY explained in plain language.
Never miss a new study
Get alerted when new ANTIPLATELET THERAPY trials appear
Sign up with your email to follow new studies for ANTIPLATELET THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart patients test life without daily blood thinners
Disease control Not yet recruitingThis study aims to find out if patients who had a special drug-coated balloon treatment for a blocked heart artery can safely stop taking daily blood-thinning pills after one year. Researchers will compare over 1,000 patients who either stop or continue their medication to see wh…
Matched conditions: ANTIPLATELET THERAPY
Phase: NA • Sponsor: Ulsan University Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Heart study aims to cut bleeding risk for seniors by shortening blood thinner regimen
Disease control Not yet recruitingThis study is testing if a much shorter course of dual blood-thinning therapy is as safe and effective as the standard longer course for seniors who get a heart stent. It will enroll 1,700 patients aged 65 and older. One group will take two blood thinners for just 7 days, then on…
Matched conditions: ANTIPLATELET THERAPY
Phase: PHASE3 • Sponsor: Vincent ROULE • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC